Fig. 3From: Estimates and trends of the global burden of NASH-related liver cancer attributable to high fasting plasma glucose in 1990–2019: analysis of data from the 2019 Global Burden of Disease StudyTemporal trend of the PAFs of the NASH-related liver cancer burden attributable to HFPG, 1990–2019. NASH: nonalcoholic steatohepatitis; SDI: socio-demographic index; HFPG: high fasting plasma glucose; DALYs, disability adjusted life years; YLLs: Years of Life Lost; YLDs: Years Lived with Disability. PAF: population attributable fractionBack to article page